Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis

Not yet recruitingNot a drug-phase studyMS (type not specified)NCT07762326

What it found

Still running

No result yet.

What was tested

Treatment tested

  • cognitive Therapy by artificial intillegence

Given to everyone in the trial

  • designed physical-therapy program

What it measured

Main measures

  • sleep disability

    up to eight weeks

    Myelin repairMood and sleep
  • daytime sleepiness

    up to eight weeks

    Mood and sleep

Other measures (5)

  • cognitive disability

    up to eight weeks

    Thinking and memoryPhysical function
  • oxygen saturation

    up to eight weeks

  • heart rate

    up to eight weeks

  • life disability

    up to eight weeks

    Quality of life (reported by participants)
  • fatigue severity

    up to eight weeks

    Fatigue

Who could take part

MS (type not specified) · 25 to 40

Show the full criteria

Inclusion criteria

* Patient's age ranges from 25-40 years. * Patient with EDSS not more than 5. * Patients who have no relapses for the previous three months. * Patients with sufficient cognitive abilities that enables them to understand and follow * instructions with a score more than 24 according to the Mini-Mental State Examination scale

Exclusion criteria

* Mechanical or neuromascular problems. * Cardiovascular problems (unstable angina, recent myocardial infarction within the last three months, congestive heart failure, significant heart valve dysfunction, or unstable hypertension) or pulmonary disorders. * Auditory problems. * Sensory impairment caused by other diseases except the MS such as diabetes mellitus.

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

this study will be conducted to investigate the effect of artificial intelligence (AI) based cognitive training on sleep disorders and quality of life in patients with multiple sclerosis.

Loading reviews and guidelines…

History

    1. Started

      Aug 2026

    2. Main results due

      Mar 2027

    3. Finished

      Mar 2027

    Assembled by software from public sources.